Juno Therapeutics, a subsidiary of Bristol Myers ( BMY) Squibb, was granted FDA orphan designation for its treatment of ...

The U.S. Food and Drug Administration has scolded Bristol Myers Squibb for making false and misleading claims about a lung cancer treatment on a website aimed at physicians. In an Aug. 1 letter, the ...

A New York City federal court has dismissed a proposed class-action lawsuit against Bristol Myers Squibb that accused the drugmaker of deploying anticompetitive tactics to protect the market ...

Bristol Myers Squibb has opened its radiopharmaceutical manufacturing facility in Indianapolis, which played a major role in the company’s $4.1 billion acquisition of RayzeBio in December 2023. The ...

Bristol Myers Squibb (BMY) is finally showing signs of life. The stock has climbed 7.3% over the last five days, adding roughly $7 billion in market value — pushing its market cap back toward $100 ...

A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades has failed a pivotal test intended to support expanding its use, a ...

Bristol-Myers Squibb is deeply undervalued despite a 23% YTD stock decline, offering compelling value in the healthcare sector. BMY faces significant patent expirations but is proactively mitigating ...